Bone marrow metastases

Hematology/Oncology Clinics of North America

Volumn 10, Issue 2, 1996, Pages 321-343

  Shpall, E J ^a   Gee, A P ^a   Hogan, C ^a   Cagnoni, P ^a   Gehling, U ^a   Hami, L ^a   Franklin, W ^a   Bearman, S I ^a   Ross, M ^a   Jones, R B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ABRIN; AMIFOSTINE; ANTINEOPLASTIC AGENT; ASTA Z; CD34 ANTIGEN; CISPLATIN; COMPLEMENT; ETOPOSIDE; GELONIN; IMMUNOTOXIN; MAFOSFAMIDE; MOMORDIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 12 8; MONOCLONAL ANTIBODY 9C5; MONOCLONAL ANTIBODY B1.3C5; MONOCLONAL ANTIBODY ICH3; MONOCLONAL ANTIBODY MY 10; MONOCLONAL ANTIBODY QBEND10; MONOCLONAL ANTIBODY TUK3; POKEWEED ANTIVIRUS PROTEIN; PREDNISONE; PSEUDOMONAS EXOTOXIN; RICIN; SAPORIN; UNCLASSIFIED DRUG; VINCRISTINE;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE MARROW PURGING; CANCER; CANCER IMMUNOTHERAPY; CELL SELECTION; CLINICAL FEATURE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE CULTURE;

EID: 0029872686     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70341-5     Document Type: Article

References (79)

1. R.G. Andrews J.W. Singer I.D. Bernstein Human hematopoietic precursors in long-term cultures: Single CD34+ cells that lack detectable T cell, B cell, and myeloid antigens produce colony-forming cells when cultured with marrow stromal cells J Exp Med 172 1990 355 361
2. E.D. Ball L.E. Mills C.T. Coughlin Autologous bone marrow transplantation in acute myelogenous leukemia: In vitro treatment with myeloid cell-specific monoclonal antibodies Blood 68 1986 1311 1315
3. L. Barbieri F. Stripe Ribosome-inactivating proteins from plants: Properties and possible uses Cancer Surv 1 1982 489 520
4. R.C. Bast P. DeFabririis J. Lipton Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement Cancer Res 45 1985 499 503
5. R. Berenson W.I. Bensinger R.S. Hill Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma Blood 77 1991 1717 1722
6. L. Bettan-Renaud F. de Vathaire J. Benard Potential therapeutic role of cisplatin in autologous bone marrow transplantation: In vitro eradication of neuroblastoma cells from bone marrow Br J Cancer 60 1989 529 532
7. M.A. Bitter D. Fiorto M.E. Corkill Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histologic examination alone Hum Pathol 25 1994 781 788
8. M. Brenner J. Mirro Jr C. Hurwitz Autologous bone marrow transplant for children with AML in first complete remission: Use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse Hum Gene Ther 2 1991 137 159
9. M.K. Brenner D.R. Rill R.C. Moen Gene-marking to trace origin of relapse after autologous bone-marrow transplantation Lancet 341 1993 85 86
10. G.M. Brodeur R.C. Seeger A. Barrett International criteria for diagnosing, staging, and response to treatment in patients with neuroblastoma J Clin Oncol 6 1988 1874 1881
11. P. Cagnoni R. Jones W. Franklin Use of CD34-positive autologous hematopoietic progenitors to support patients with breast cancer after high-dose chemotherapy Blood 86 1995 386a 1533
12. G. Ceci V. Franciosi R. Passalacqua The value of bone marrow biopsy in breast cancer at the time of first relapse. A prospective study Cancer 61 1988 1041 1045
13. N. Chao M. Aihara K.G. Blume Bone marrow purging combining a monoclonal antibody against and VP-16 Exp Hematol 18 1990 674
14. C. Civin T. Trischmann J. Davis Highly purified CD34+ cells reconstitute hematopoiesis Proc Am Soc Clin Oncol 14 1995 437
15. C.I. Civin L.C. Strauss C. Brovall Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells J Immunol 133 1984 157 162
16. C.I. Civin L.C. Strauss M. Fackler Positive stem cell science Bone marrow purging and processing Prog Clin Biol Res 333 1990 387 402
17. Clinical significance of bcr-abl gene rearrangement by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia Blood 78 1991 2759 2777
18. D.M. Coen The Polymerase Chain Reaction F.M. Ausbel Current Protocols in Molecular Biology 1992 Greene Publishing and John Wiley & Sons Philadelphia 12 15.1-15.7.5.
19. R.J. Cote P.P. Rosen T.B. Hakes Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease Am J Surg Pathol 12 1988 333 340
20. R.J. Cote P.P. Rosen M.L. Lesser Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases J Clin Oncol 9 1991 1749 1756
21. D. Crisan C. Sing-Tsung S. Weil Polymerase chain reaction in the diagnosis of chromosomal breakpoints Hematol Oncol Clin North Am 8 1994 725 745
22. D.P. Dearnaley J.P. Sloane M.G. Ormerod Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen Br J Cancer 44 1981 85 90
23. P. DeFabritiis M. Bregni J. Lipton Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-HC in combination with monoclonal antibodies and complement Blood 65 1985 1064 1079
24. L. Douay J.Y. Mary M.C. Giarrantana Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (Asta Z 7557) Exp Hematol 17 1989 429 432
25. M. Drew R.B. Dickinson Osseous complications of malignancy J. Lokich Clinical Cancer Medicine, Treatment Tactics 1980 GK Hall Boston 97 124
26. A.A. Fauser K. Lothar P. Casellas Reconstitution of hematopoiesis after bone marrow purging with ricin A chain immunotoxin Transplantation 41 1986 356 360
27. K.K. Fields L.C. Moscinski W.L. Trudeau Polymerase chain reaction evaluation of bone marrow micrometastases in metastatic breast cancer Breast Cancer Res Treat 27 1993 144
28. L. Fina H.V. Molgaard D. Robertson Expression of the CD34 gene in vascular endothelial cells Blood 74 1990 2417
29. A.P. Gee M.D. Boyle Purging tumor cells from bone marrow by use of antibody and complement: A critical appraisal J Natl Cancer Inst 80 1988 154 159
30. A. Gee K. Bruce T. Morris Evidence for an anti-complementary factor associated with normal bone marrow cells J Natl Cancer Inst 75 1985 441 445
31. A.P. Gee C. Lee K. Bruce Immunomagnetic purging and autologous transplantation in stage D neuroblastoma Bone Marrow Transplant 2 1987 89 93
32. A.L. Givan Instrumentation: Beyond the black box Flow Cytometry First Principles 1992 Wiley-Liss New York 15 40
33. H. Green B. Goldberg The action of antibody and complement on mammalian cells Ann NY Acad Sci 87 1960 352 362
34. J.C. Gribben A.S. Freedman D. Neuberg Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma N Engl J Med 325 1991 1525 1533
35. N. Gorin L. Douay M. Laporte Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia Blood 67 1986 1367 1376
36. O. Hartmann E. Benhamou F. Beaujean Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma J Clin Oncol 5 1987 1205 1211
37. L.J. Horwitz M.L. Auber S. Khorana 4-HC and vincristine as ex vivo marrow treatment for acute leukemia in second remission K. Dicke G. Spitzer S. Jagannath Third International Symposium on Autologous Bone Marrow Transplantation 1987 The University of Texas MD Anderson Hospital and Tumor Institute 143 150
38. J.N. Ingle D.C. Tormey H.K. Tan The bone marrow examination in breast cancer: Diagnostic considerations and clinical usefullness Cancer 41 1978 670 674
39. R.J. Jones C.B. Miller B.A. Zehnbauer In vitro evaluation of combination purging for autologous bone marrow transplantation Bone Marrow Transplant 5 1990 301 307
40. C. Kamby I. Vejborg S. Daugaard Clinical and radiologic characteristics of bone metastases in breast cancer Cancer 60 1987 2524 2531
41. F. Katz R.W. Tindle D.R. Sutherland M.F. Greaves Identification of a membrane glycoprotein associated with hematopoietic progenitor cells Leuk Res 9 1985 191
42. M.J. Kennedy R.A. Beveridge S.D. Rowley High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer J Natl Cancer Inst 83 1991 920 926
43. P.M. Lansdorp W. Dragowska H. Mayani Ontogeny-related changes in proliferative potential of human cells J Exp Med 178 1993 787 791
44. T.W. LeBien J.M. Anderson D.A. Vallera F. Uckun Increased efficacy of selective elimination of leukemic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 plus complement and mafosfamide (Asta-Z-7557) Leuk Res 10 1985 139 143
45. J.S. Lebkowski L.R. Schain D. Okrongly Rapid isolation of human CD34 hematopoietic stem cells—purging of human tumor cells Transplantation 53 1992 1011 1019
46. L. Mattano T. Moss Emerson Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase polymerase chain reaction Cancer Res 52 1992 4701 4705
47. S. Miltenyi W. Muller W. Weichel A. Radbruch High-gradient magnetic cell separation with MACS Cytometry 11 1990 231 236
48. S. Morecki S. Margel Slavin Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow Cancer Res 48 1988 4573 4577
49. K.B. Mullis F. Faloona S.J. Scharf Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction Cold Spring Harb Symp Quant Biol 51 1986 263 273
50. S.J. Noga J.E. Wagner S.D. Rowley Using elutriation to engineer bone marrow allografts S. Gross A. Gee D. Worthington-White Bone Marrow Purging and Processing vol 333 1990 Wiley-Liss New York 344 368
51. S.H. Ohanian S.I. Schlager Humoral immune killing of nucleated cells: Mechanisms of complement-mediated attack and target cell defense Crit Rev Immunol 1 1981 165 209
52. M.P. Osborne P.P. Rosen Detection and management of bone marrow micrometastases in breast cancer Oncology 8 1994 25 31
53. M.P. Osborne G.Y. Wong S. Asina Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow Cancer Res 51 1991 2706 2709
54. M.P. Osborne G.Y. Wong A. Gonzales Bone marrow micrometastases in breast cancer: The effect of systemic tumor burden on early relapse Proc Am Soc Clin Oncol 12 1993 75
55. G. Pittman K. Tung Hoffman Metastatic cells in bone marrow Clev Clinic Q 38 1971 55 74
56. Y. Reisner N. Kapoor D. Kirkpatrick Transplantation for severe combined (SCID) with histocompatible parental marrow fractionated by soybean agglutinin and sheep red blood cells: Experience in six consecutive cases Transplant Proc 15 1983 1431 1435
57. G. Schlimok I. Funke B. Holzmann Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies Proc Natl Acad Sci USA 84 1987 8672 8676
58. J.C. Sharp A. Kessinger S. Mann Detection and clinical significance of minimal tumor cell contamination of peripheral blood stem cell harvests International Journal of Cell Cloning 10 Suppl 1 1992 92 94
59. E.J. Shpall R.C. Bast W.T. Joines Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation Bone Marrow Transplant 7 1991 145 151
60. E.J. Shpall C. Johnston L. Hami Amifostine (WR-2721) shortens the engraftment period of 4 hydroperoxycyclophosphamide purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support Blood 83 1994 3132 3137
61. E.J. Shpall R.B. Jones R.C. Bast 4-HC purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial J Clin Oncol 9 1991 85 93
62. E.J. Shpall R.B. Jones W. Franklin Transplantation of enriched CD34 positive (+) autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34 + peripheral blood progenitors and growth factors on engraftment J Clin Oncol 12 1994 28 36
63. I. Slapper-Cortenbach A. De Vries van Rossen R. Huijbens Neuroblastoma purging by immunorosette depletion S. Gross A. Gee D. Worthington-White Bone Marow Purging and Processing vol 377 1992 Wiley-Liss New York 147 162
64. J. Sloane M.C. Ormerod A.M. Neville Potential pathological application of immunocytochemical methods to the detection of Cancer Res 40 1980 3079 3082
65. A. Takimazawa S. Matsumoto T. Iwata Studies on cyclophosphamide metabolites and their related compounds. II. Preparation of an acute species of cyclophosphamide and related compounds Journal of the American Chemical Society 95 1973 985 986
66. C. Tondini S.A. Pap D.F. Hayes Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow Cancer Res 50 1990 1170 1175
67. B. Uchanska-Ziegler S. Petrasch J. Michel A. Ziegler Characterization of the CD34-specific monoclonal antibody TUK3 Tissue Antigens 33 1989 230
68. N. Uchida A. Combs S. Conti The in vivo population of a rhodamine 123 low population of human marrow Exp Hematol 22 1994 755
69. F. Uckun S. Ramakrishnan L. Houston Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell specific immunotoxin containing pokeweed antiviral protein Cancer Res 45 1985 69 75
70. F. Uckun G. Kazimiera D. Meyers Marrow purging in autologous bone marrow transplantation for T-lineage ALL: Efficacy of ex vivo treatment with immunotoxins and 4 hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells Blood 69 1987 361 366
71. J. Ugelstad H.R. Mfutakamba P.C. Mork Preparation and application of monodisperse polymer particles Journal of Polymer Science 72 1985 225 240
72. D.A. Vallera Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation A.E. Frankel Immunotoxins 1988 Kluwer Academic Publishers Hingham, MA 515 531
73. W.P. Vaughn S.L. Mann J. Garvey Breast cancer detected in cell culture of histologically negative bone marrow predicts systemic relapse in patients with stage I, II, III and locally recurrent disease Proc Am Soc Clin Oncol 9 1990 9
74. C. Verfaille W. Miller K. Boylan P. McGlave Selection of benign primitive progenitors in CML on the basis of HLA-DR antigen expression Blood 79 1992 1003 1010
75. T.H. Wasserman T.L. Phillips G. Ross Differential protection against chemotherapeutic effects on bone marrow CFUs by WR-2721 Cancer Clinical Trials 4 1981 3 6
76. S.M. Watt K. Karhi K. Gatter Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hematopoietic progenitor cells Leukaemia 1 1987 41
77. Q. Wei F. Barany V.I. Wilson Oncogenic point mutations detected by combined PCR and LCR techniques. 32nd Annual Meeting of the American Society of Cell Biology Mol Biol Cell 3 Suppl 1994 22A
78. J. Winter R. Marder B. Mankad Heterogeneity among non-Hodgkin's lymphomas: Implications for autologous bone marrow transplantation with in vitro purging using monoclonal antibodies Cancer 61 1988 1082 1090
79. A. Yeager H. Kaizer G. Santos Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-HC N Engl J Med 315 1986 114 147